Macular structure and function after intravitreal injection of bevacizumab for wet macular degeneration a interventional study.

Registry ID

EUCTR2005-006014-18

Source registry

EUCTR

Status

Completed

Phase

PHASE2

Sponsor

POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI

Start date

2005-02-15

Last update

2026-08-16

Conditions

• Macular degeneration

Summary

To assess macular structure and function by visual acuity ETDRS , optical coherence tomography OCT3 , focal electroretinogram FERG , microperimetry, fluorescein and indocyanine angiography before and after intravitreal bevacizumab administration for wet age related macular degeneration.

Locations

• , , Italy

Related clinical trials

• LADIGAGA - Long–term Analysis of DImethyl fumarate, to slow the Growth of Areas of Geographic Atrophy

View on source registry